Government may soon lift export curbs on RAT, RT-PCR kits

NEW DELHI: After Covid vaccines, PPE kits and hand sanitisers, the government may now soon lift export restrictions from RT-PCRrapid antigen test (RAT) and RNA extraction kits etc.

The health ministry has recommended revoking export restrictions imposed on Covid-19 diagnostic kits which were imposed earlier in the wake of large number of infected cases in the country.

In a letter to the directorate general of foreign trade (DGFT), the health ministry has suggested free export of such products. The recommendations are based on deliberations in a meeting of the related Empowered Group-6 in September. The group has decided to revoke the restrictions and allow free export of these products, till further intimation, the letter said. TOI has reviewed a copy of the letter. The final call will be taken by DGFT.

Diagnostic kits, including RT-PCR kits, RNA extraction kits and VTMs were added under restricted category for exports by the DGFT from June 2020, while RAT kits were included in the list in August 2021.

  • Related Posts

    • Pharma
    • June 24, 2025
    • 58 views
    India’s herbal and ayurvedic OTC market set to outpace global growth

    New Delhi: India’s herbal and ayurvedic OTC (over the counter) market is expected to grow at a CAGR of 6.5 per cent, from $69 million in 2025 to $118 million…

    • Pharma
    • June 23, 2025
    • 127 views
    Ananda Pharma completes GMP manufacturing of MRX1 for clinical trials

    LONDON:  Ananda Pharma PLC (AQSE:ANA, OTCQB: ANANF) has manufactured 40 liters of its lead investigational product MRX1 and 40 liters of matched placebo in compliance with pharmaceutical Good Manufacturing Practices…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    India’s herbal and ayurvedic OTC market set to outpace global growth

    India’s herbal and ayurvedic OTC market set to outpace global growth

    Ananda Pharma completes GMP manufacturing of MRX1 for clinical trials

    Ananda Pharma completes GMP manufacturing of MRX1 for clinical trials

    Ray of hope for HIV patients, as Hyderabad-based pharma giants secure nod for game-changing HIV drug

    Ray of hope for HIV patients, as Hyderabad-based pharma giants secure nod for game-changing HIV drug

    Drug licences of 9 pharma dealers suspended in Jammu

    Drug licences of 9 pharma dealers suspended in Jammu